Evidence map›Paper›PMID 37359730›Full record

ArticleRegenerative biomaterials2023

Chitin nanocrystal-assisted 3D bioprinting of gelatin methacrylate scaffolds.

Zhengyun Ling, Jian Zhao, Shiyu Song, Shuwei Xiao, Pengchao Wang, Ziyan An, Zhouyang Fu, Jinpeng Shao, Zhuang Zhang, Weijun Fu and 1 more

Erratum issuedAbstract read
In one paragraph

Article in Regenerative biomaterials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Zhengyun LingSchool of Medicine, Nankai University, Tianjin 300071, China.ORCID https://orcid.org/0000-0003-2934-5347
Jian ZhaoMedical School of PLA, Beijing 100853, China.
Shiyu SongUndergraduate Student Majoring in Clinical Pharmacy, Chongqing Medical University, Chongqing 400016, China.
Shuwei XiaoDepartment of Urology, Air Force Medical Center, Beijing 100142, China.
Pengchao WangDepartment of Urology, The Third Medical Center, PLA General Hospital, Beijing 100039, China.
Ziyan AnDepartment of Urology, The Third Medical Center, PLA General Hospital, Beijing 100039, China.
Zhouyang FuDepartment of Urology, The Third Medical Center, PLA General Hospital, Beijing 100039, China.
Jinpeng ShaoDepartment of Urology, The Third Medical Center, PLA General Hospital, Beijing 100039, China.
Zhuang ZhangBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Weijun FuSchool of Medicine, Nankai University, Tianjin 300071, China.ORCID https://orcid.org/0000-0001-6904-7497
Shenghan SongDepartment of Vascular Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.ORCID https://orcid.org/0000-0002-2611-5207

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, there has been an increasing focus on the application of hydrogels in tissue engineering. The integration of 3D bioprinting technology has expanded the potential applications of hydrogels. However, few commercially available hydrogels used for 3D biological printing exhibit both excellent biocompatibility and mechanical properties. Gelatin methacrylate (GelMA) has good biocompatibility and is widely used in 3D bioprinting. However, its low mechanical properties limit its use as a standalone bioink for 3D bioprinting. In this work, we designed a biomaterial ink composed of GelMA and chitin nanocrystal (ChiNC). We explored fundamental printing properties of composite bioinks, including rheological properties, porosity, equilibrium swelling rate, mechanical properties, biocompatibility, effects on the secretion of angiogenic factors and fidelity of 3D bioprinting. The results showed that adding 1% (w/v) ChiNC to 10% (w/v) GelMA improved the mechanical properties and printability of the GelMA hydrogels, promoted cell adhesion, proliferation and vascularization and enabled the printing of complex 3D scaffolds. This strategy of incorporating ChiNC to enhance the performance of GelMA biomaterials could potentially be applied to other biomaterials, thereby expanding the range of materials available for use. Furthermore, in combination with 3D bioprinting technology, this approach could be leveraged to bioprint scaffolds with complex structures, further broadening the potential applications in tissue engineering.

Indexed as

3D bioprintingchitin nanocrystalgelatin methacrylatehydrogelsscaffolds

Identifiers

PMID37359730
PMCPMC10290201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.